Literature DB >> 18519404

Prognostic factors in chronic lymphocytic leukemia.

M Hallek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18519404     DOI： 10.1093/annonc/mdn196

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  Utility of laboratory tests in B-CLL patients in different clinical stages.

Authors:  Małgorzata Rusak; Joanna Osada; Joanna Pawlus; Joanna Chociej-Stypułkowska; Milena Dąbrowska; Janusz Kłoczko
Journal:  Int J Hematol       Date:  2011-05-28       Impact factor: 2.490

2.  BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysis.

Authors:  Sara Samuel; Vladimir Beljanski; Julien Van Grevenynghe; Stephanie Richards; Fethia Ben Yebdri; Zhong He; Carmen Nichols; S Mehdi Belgnaoui; Courtney Steel; Marie-Line Goulet; April Shamy; Dawn Brown; Guillermo Abesada; Elias K Haddad; John Hiscott
Journal:  Mol Ther       Date:  2013-05-21       Impact factor: 11.454

3.  De novo deletion 17p13.1 as a predictor for disease progression in chronic lymphocytic leukemia.

Authors:  Amro M S El-Ghammaz; Essam Abdelwahed; Nevine N Mostafa; Dina A Mansour
Journal:  Clin Exp Med       Date:  2014-10-10       Impact factor: 3.984

4.  Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison.

Authors:  Suzy Van Sanden; Simona Baculea; Joris Diels; Sarah Cote
Journal:  Adv Ther       Date:  2017-06-01       Impact factor: 3.845

5.  TP53 Staining in Tissue Samples of Chronic Lymphocytic Lymphoma Cases: An Immunohistochemical Survey of 51 Cases.

Authors:  İbrahim Kulaç; Çetin Demir; Yahya Büyükaşık; Tezer Kutluk; Ayşegül Üner
Journal:  Turk J Haematol       Date:  2016-05-12       Impact factor: 1.831

6.  Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017.

Authors:  Branimir Jakšić; Vlatko Pejša; Slobodanka Ostojić-Kolonić; Ika Kardum-Skelin; Sandra Bašić-Kinda; Božena Coha; Velka Gverić-Krečak; Radovan Vrhovac; Ozren Jakšić; Igor Aurer; Jasminka Sinčić-Petričević; Antica Načinović-Duletić; Damir Nemet
Journal:  Acta Clin Croat       Date:  2018-03       Impact factor: 0.932

7.  The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naïve patients with chronic lymphocytic leukemia

Authors:  Sinem Nihal Esatoğlu; Dilek Keskin; Ahmet Emre Eşkazan; Tuğrul Elverdi; Ayşe Salihoğlu; Muhlis Cem Ar; Şeniz Öngören; Zafer Başlar; Yildiz Aydin; Hafize Uzun; Teoman Soysal
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.